SG160430A1 - Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods - Google Patents
Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methodsInfo
- Publication number
- SG160430A1 SG160430A1 SG201001981-8A SG2010019818A SG160430A1 SG 160430 A1 SG160430 A1 SG 160430A1 SG 2010019818 A SG2010019818 A SG 2010019818A SG 160430 A1 SG160430 A1 SG 160430A1
- Authority
- SG
- Singapore
- Prior art keywords
- immune modulators
- preparations
- compositions
- compositions including
- immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70514—CD4
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84834806P | 2006-09-29 | 2006-09-29 | |
US11/855,944 US10471100B2 (en) | 2006-09-29 | 2007-09-14 | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
Publications (1)
Publication Number | Publication Date |
---|---|
SG160430A1 true SG160430A1 (en) | 2010-04-29 |
Family
ID=39261440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201001981-8A SG160430A1 (en) | 2006-09-29 | 2007-09-19 | Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods |
Country Status (15)
Country | Link |
---|---|
US (2) | US10471100B2 (fr) |
EP (1) | EP2068913B1 (fr) |
JP (3) | JP5592651B2 (fr) |
CN (1) | CN101553247B (fr) |
AU (1) | AU2007305076B2 (fr) |
CO (1) | CO6220833A2 (fr) |
EC (1) | ECSP099296A (fr) |
ES (1) | ES2658107T3 (fr) |
HK (1) | HK1138181A1 (fr) |
MX (1) | MX2009003324A (fr) |
MY (2) | MY158857A (fr) |
RU (2) | RU2518341C2 (fr) |
SG (1) | SG160430A1 (fr) |
TW (1) | TWI449530B (fr) |
WO (1) | WO2008042604A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11197894B2 (en) | 2006-09-29 | 2021-12-14 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
AU2006242106B2 (en) * | 2005-05-02 | 2013-01-17 | 4Life Patents, Llc | Transfer factor preparations and associated methods |
US9028882B2 (en) | 2005-05-02 | 2015-05-12 | 4Life Patents, Llc | Nutraceutical gels |
TW201105966A (en) * | 2009-05-05 | 2011-02-16 | 4Life Patents Llc | Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject |
EP3424531A1 (fr) | 2010-11-23 | 2019-01-09 | Pantheryx, Inc. | Compositions et procédés de traitement dans des applications cliniques à large spectre, non différenciées ou mélangées |
CN102172360B (zh) * | 2011-02-17 | 2013-04-24 | 南京大学 | 一种牛初乳提取物及其提取方法和应用 |
WO2013039373A2 (fr) * | 2011-09-13 | 2013-03-21 | Zepeda Lopez Hector Manuel | Extrait dialysé de leucocytes issu de rate de requin utilisé pour obtenir un facteur de transfert potentialisé, et procédé d'extraction, d'essai et de comptage de ce dernier |
WO2013039374A2 (fr) * | 2011-09-15 | 2013-03-21 | Zepeda Lopez Hector Manuel | Procédé d'extraction, d'essai et de comptage d'extrait dialysé de leucocytes provenant de rate de requin, pour obtenir un facteur de transfert potentialisé, spécifiquement conçu pour être utilisé en tant que traitement contre la maladie connue sous le nom de vitiligo |
WO2013043032A2 (fr) * | 2011-09-19 | 2013-03-28 | Zepeda Lopez Hector Manuel | Extrait dialysé de leucocytes issu de rate de requin utilisé pour obtenir un facteur de transfert potentialisé, spécifiquement conçu pour être utilisé en tant qu'immunomodulateur et procédé d'extraction, d'essai et de comptage de ce dernier |
WO2013043033A2 (fr) * | 2011-09-19 | 2013-03-28 | Zepeda Lopez Hector Manuel | Procédé d'extraction et d'essai d'extrait dialiysé de leucocytes provenant de rate de requin, pour obtenir un facteur de transfert potentialisé, spécifiquement conçu pour être utilisé en tant qu'adjuvant potentialisateur de vaccins viraux |
WO2013058640A2 (fr) * | 2011-10-20 | 2013-04-25 | Zepeda Lopez Hector Manuel | Procédé d'extraction, d'essai et de comptage d'extrait dialysé de leucocytes provenant de rate de requin, pour obtenir un facteur de transfert potentialisé, spécifiquement conçu pour être utilisé en tant que traitement contre la maladie connue sous le nom d'asthme |
MX338863B (es) * | 2011-12-16 | 2016-05-01 | Inst Politecnico Nacional | Metodo de obtencion de extracto dializable de leucocitos. |
WO2015054694A2 (fr) | 2013-10-13 | 2015-04-16 | 4Life Patents, Llc | Compositions thérapeutiques et procédés de gestion des contraintes physiologiques et du vieillissement |
KR101597540B1 (ko) * | 2014-01-22 | 2016-02-29 | 건국대학교 산학협력단 | 난황 추출물을 유효성분으로 함유하는 면역증강용 조성물 |
WO2018232313A2 (fr) * | 2017-06-15 | 2018-12-20 | Miradx | Biomarqueurs pour prédire une réponse tumorale à une immunothérapie et la toxicité d'une immunothérapie |
US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4402938A (en) * | 1980-05-29 | 1983-09-06 | Impro Products, Inc. | Food and the method of extracting the same from colostrum and milk |
US4816563A (en) * | 1983-11-25 | 1989-03-28 | Amtron, Inc. | Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof |
JPS60208919A (ja) * | 1983-11-25 | 1985-10-21 | アムトロン・インコ−ポレイテツド | トランスフア−フアクタ−を初乳から得る方法、こうして得られたトランスフア−フアクタ−及びその使用 |
US5585098A (en) * | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
JP4127724B2 (ja) * | 1996-03-26 | 2008-07-30 | サイレックス インコーポレーテッド | リンパ球機能の測定方法 |
NZ504132A (en) | 1996-03-26 | 2002-03-28 | Dcv Inc | Anti-inflammatory composition from avian eggs, method of isolation and use in treating and preventing inflammation |
US7169571B2 (en) * | 1997-09-12 | 2007-01-30 | Cylex, Inc. | Methods for measurement of lymphocyte function |
CZ287956B6 (cs) * | 1997-11-04 | 2001-03-14 | Medipharm Cz, S. R. O. | Perorální přípravek k prevenci a léčbě parvovirózy psů |
US20020044942A1 (en) * | 2000-09-18 | 2002-04-18 | Chisolm Biological Laboratory, Llc | Transfer factor composition and process for producing same |
US6468534B1 (en) | 2000-09-21 | 2002-10-22 | 4Life Research, Lc | Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use |
WO2002038164A1 (fr) | 2000-11-08 | 2002-05-16 | Lorus Therapeutics Inc. | Preparation combinee d'un modificateur de reponse biologique et d'un agent anticancereux et utilisations de cette derniere |
US20030003117A1 (en) * | 2001-06-18 | 2003-01-02 | Michael Marenick | Hydrolyzed whole egg products & related methods |
KR20040105710A (ko) * | 2002-02-11 | 2004-12-16 | 아르키온 라이프 사이언씨즈 엘엘씨 | 정제된 사이토킨 억제인자 |
US20040005327A1 (en) * | 2002-05-16 | 2004-01-08 | Subramanian Iyer | Immune T-cell stimulation |
WO2004041071A2 (fr) | 2002-11-04 | 2004-05-21 | 4Life Research, Lc | Compositions, systemes et methodes permettant de focaliser une reponse immunitaire a mediation cellulaire |
CN1460522A (zh) | 2003-06-16 | 2003-12-10 | 郭占军 | 预防和治疗疾病的蛋黄抗体组合物及其制备方法 |
US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
US10471100B2 (en) | 2006-09-29 | 2019-11-12 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
CN100502674C (zh) | 2005-10-13 | 2009-06-24 | 复旦大学 | 一种牛初乳和香菇提取物组合物及其制备方法和用途 |
-
2007
- 2007-09-14 US US11/855,944 patent/US10471100B2/en active Active
- 2007-09-19 AU AU2007305076A patent/AU2007305076B2/en active Active
- 2007-09-19 EP EP07814934.1A patent/EP2068913B1/fr active Active
- 2007-09-19 MX MX2009003324A patent/MX2009003324A/es active IP Right Grant
- 2007-09-19 RU RU2009116274/15A patent/RU2518341C2/ru active
- 2007-09-19 SG SG201001981-8A patent/SG160430A1/en unknown
- 2007-09-19 WO PCT/US2007/078947 patent/WO2008042604A2/fr active Application Filing
- 2007-09-19 CN CN200780039690.XA patent/CN101553247B/zh active Active
- 2007-09-19 JP JP2009530527A patent/JP5592651B2/ja active Active
- 2007-09-19 MY MYPI20091276A patent/MY158857A/en unknown
- 2007-09-19 ES ES07814934.1T patent/ES2658107T3/es active Active
- 2007-09-27 TW TW096135902A patent/TWI449530B/zh active
-
2009
- 2009-03-27 MY MYPI2013003021A patent/MY188915A/en unknown
- 2009-04-29 CO CO09043396A patent/CO6220833A2/es active IP Right Grant
- 2009-04-29 EC EC2009009296A patent/ECSP099296A/es unknown
-
2010
- 2010-04-07 HK HK10103400.6A patent/HK1138181A1/zh unknown
-
2014
- 2014-01-27 RU RU2014102562A patent/RU2619555C2/ru active
- 2014-03-10 JP JP2014046094A patent/JP2014129413A/ja active Pending
-
2016
- 2016-06-22 JP JP2016123656A patent/JP6401744B2/ja active Active
-
2019
- 2019-11-11 US US16/679,908 patent/US11197894B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11197894B2 (en) | 2006-09-29 | 2021-12-14 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
Also Published As
Publication number | Publication date |
---|---|
JP2010504988A (ja) | 2010-02-18 |
US20080081076A1 (en) | 2008-04-03 |
CN101553247A (zh) | 2009-10-07 |
US10471100B2 (en) | 2019-11-12 |
HK1138181A1 (zh) | 2010-08-20 |
US11197894B2 (en) | 2021-12-14 |
ECSP099296A (es) | 2010-02-26 |
RU2014102562A (ru) | 2015-08-20 |
CO6220833A2 (es) | 2010-11-19 |
EP2068913A4 (fr) | 2009-12-02 |
CN101553247B (zh) | 2015-08-19 |
RU2619555C2 (ru) | 2017-05-16 |
ES2658107T3 (es) | 2018-03-08 |
EP2068913B1 (fr) | 2017-11-01 |
MY158857A (en) | 2016-11-15 |
TWI449530B (zh) | 2014-08-21 |
EP2068913A2 (fr) | 2009-06-17 |
WO2008042604A3 (fr) | 2008-11-06 |
RU2009116274A (ru) | 2010-11-10 |
JP2014129413A (ja) | 2014-07-10 |
MX2009003324A (es) | 2009-06-30 |
AU2007305076B2 (en) | 2011-04-28 |
JP2016196491A (ja) | 2016-11-24 |
JP6401744B2 (ja) | 2018-10-10 |
RU2518341C2 (ru) | 2014-06-10 |
US20200069737A1 (en) | 2020-03-05 |
JP5592651B2 (ja) | 2014-09-17 |
WO2008042604A2 (fr) | 2008-04-10 |
MY188915A (en) | 2022-01-13 |
AU2007305076A1 (en) | 2008-04-10 |
TW200831116A (en) | 2008-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG160430A1 (en) | Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods | |
BRPI0503828A (pt) | formulações contendo pó, aquosas, lìquidas, não alcoólicas | |
WO2009061681A3 (fr) | Antagonistes de récepteurs pgd2 | |
TN2011000161A1 (en) | Fgf21 mutants and uses thereof | |
WO2006101955A3 (fr) | Compositions de revetement liquide | |
MY152721A (en) | Fgf21 mutants and uses thereof | |
MY156542A (en) | Fgf21 mutants and uses thereof | |
WO2007041511A3 (fr) | Kinase des progeniteurs hematopoietiques 1 destinee a la modulation d'une reponse immune | |
ATE480223T1 (de) | Kosmetische zusammensetzungen mit blockcopolymeren und entsprechendes system von dauerhaften kosmetikprodukten | |
WO2006053010A3 (fr) | Utilisation d'antioxydants dans la modulation genique | |
WO2006060182A3 (fr) | Peptides hk hautement ramifies utilises en tant que porteurs efficaces de petits arn interferents | |
WO2010025421A3 (fr) | Modulateurs de myc, procédés d'utilisation de ces derniers et procédés d'identification d'agents modulant myc | |
NO20065051L (no) | Bazedoksifenacetat faste dispersjonsfomuleringer | |
WO2008073174A3 (fr) | Thérapie antimicrobienne | |
MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
MX2010013913A (es) | 5-fenil-isoxazol-3-carboxamidas que modulan hsp90 con actividad antitumoral. | |
NZ596813A (en) | Drug delivery systems | |
WO2007041364A3 (fr) | Methodes et compositions permettant de moduler la tolerance immunitaire | |
WO2009017719A8 (fr) | Modulateurs du récepteur ccr9 et leurs procédés d'utilisation | |
WO2009040512A3 (fr) | Modulation de rsk | |
WO2008027855A3 (fr) | Compositions et procédés pour moduler la signalisation de mtor | |
DK0852623T3 (da) | Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler | |
WO2007002093A3 (fr) | Formulations d'ansamycine et leurs procedes d'utilisation | |
WO2006031786A3 (fr) | Compositions de proteine a et procedes d'utilisation | |
WO2003083057A3 (fr) | Adipocytes et leurs utilisations |